Premenstrual Syndrome Clinical Trial
— PMSOfficial title:
The Effect of Pilates Exercise and Whatsapp Text-Based Support Program on Premenstrual Syndrome (PMS) Symptoms: A Randomized Controlled Study
NCT number | NCT05290181 |
Other study ID # | ABalmumcu |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 12, 2022 |
Est. completion date | June 5, 2022 |
Verified date | February 2023 |
Source | Aydin Adnan Menderes University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the effect of Pilates exercise and Whatsapp text message-based support program on PMS symptoms experienced by university female students.
Status | Completed |
Enrollment | 68 |
Est. completion date | June 5, 2022 |
Est. primary completion date | March 2, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Having regular menstrual cycles (intervals of 21-35 days, lasting 3-10 days), - Body mass index of 18.5-24.9 kg/m. to be between - Absence of chronic disease, - Absence of a hormonal disease such as polycystic ovary syndrome, - Using smart mobile phone - Not using oral contraceptives or antidepressants. Exclusion Criteria: - - Having a chronic or physical illness that prevents Pilates. |
Country | Name | City | State |
---|---|---|---|
Turkey | Aydin Adnan Menderes University | Aydin | Söke |
Lead Sponsor | Collaborator |
---|---|
Aydin Adnan Menderes University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Premenstrual syndrome scale (PMSS) | The premenstrual syndrome scale (PMSS) aims to measure the severity of symptoms. The scale consists of 44 items in 5-point Likert type. The Cronbach's alpha value of the scale was determined as 0.75. As stated in the PMSS directive, while filling out the scale, the participants should mark according to the symptoms they felt one week before the period. In scoring the scale, the "Never" option is 1 point, the "Very little" option is 2 points, the "Sometimes" option is 3 points, the "Frequently" option is 4 points, and the "Constantly" option is evaluated. as 5 points. While evaluating the PMSS results, the presence of PMS is evaluated according to the condition of passing 50% of the highest score that can be obtained from the total and subscale scores. The highest possible score for the total score is 220, 50% of which is 110. A score above 110 points on the scale indicates the presence of PMS. | Baseline | |
Secondary | Premenstrual syndrome scale (PMSS) | The premenstrual syndrome scale (PMSS) aims to measure the severity of symptoms. The scale consists of 44 items in 5-point Likert type. The Cronbach's alpha value of the scale was determined as 0.75. As stated in the PMSS directive, while filling out the scale, the participants should mark according to the symptoms they felt one week before the period. In scoring the scale, the "Never" option is 1 point, the "Very little" option is 2 points, the "Sometimes" option is 3 points, the "Frequently" option is 4 points, and the "Constantly" option is evaluated. as 5 points. While evaluating the PMSS results, the presence of PMS is evaluated according to the condition of passing 50% of the highest score that can be obtained from the total and subscale scores. The highest possible score for the total score is 220, 50% of which is 110. A score above 110 points on the scale indicates the presence of PMS. | Immediately after the 8-week support intervention program |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02481973 -
The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome
|
Phase 2 | |
Completed |
NCT00195559 -
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
|
Phase 3 | |
Completed |
NCT00048854 -
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00965562 -
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
|
N/A | |
Completed |
NCT05349344 -
Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).
|
N/A | |
Recruiting |
NCT06146673 -
A Multidimensional Study of Premenstrual Syndrome and Body Image
|
||
Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
Completed |
NCT05499000 -
The Effect of Emotional Freedom Technique on Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06144073 -
The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06105567 -
The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress
|
N/A | |
Completed |
NCT03298607 -
The Impact of Serelys PMS on Symptoms of PMS
|
Phase 3 | |
Recruiting |
NCT06176313 -
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
|
N/A | |
Recruiting |
NCT02562053 -
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
|
Phase 3 | |
Completed |
NCT00229346 -
Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
|
N/A | |
Completed |
NCT00516113 -
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
|
Phase 4 | |
Completed |
NCT04901598 -
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
|
||
Completed |
NCT05692479 -
Premenstrual Syndrome and Physical Activity Self-Worth
|
||
Not yet recruiting |
NCT06052722 -
The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders
|
N/A | |
Completed |
NCT05665972 -
Effects of Mandala Coloring on Premenstrual Syndrome
|
N/A | |
Completed |
NCT05556252 -
The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life
|
N/A |